S039 Atopic Dermatitis
DESCRIPTION
Up-to-date overview about atopic dermatitis, new discoveries, and new therapies. The session is directed towards dermatologists/health providers who treat atopic dermatitis. Moderated by Drs. Paller and Drucker, Topics are: Epidemiology of Atopic Dermatitis (Dr. Drucker); Epidermal Barrier and Immune Dysregulation (Dr. Beck); Pathogenesis of Itch and its Treatment (Dr. Kim); Topical Therapy (Dr. Eichenfield); Systemics for Pediatric Patients (Dr Paller); and Systemic Therapy for Adults, including Emerging Therapies (Dr. Simpson). Participants are encouraged to bring questions for the panel discussion at the end.
LEARNING OBJECTIVES
Recognize the high burden of atopic dermatitis
Identify barrier, neurologic, and immune shifts in atopic dermatitis that form the basis for new therapies
Use the available and emerging therapies in making decisions about atopic dermatitis management
SCHEDULE
1:00 PM
Introduction
Amy S. Paller, MD, FAAD, Aaron Mark Drucker, MD, FAAD
1:05 PM
Epidemiology of Atopic Dermatitis
Aaron Mark Drucker, MD, FAAD
1:15 PM
Epidermal Barrier and Immune Dysregulation
Lisa A. Beck, MD, FAAD
1:40 PM
Pathogenesis and Treatment of Itch in Atopic Dermatitis
Brian S. Kim, MD, FAAD
2:05 PM
Questions and Comments
Lisa A. Beck, MD, FAAD, Aaron Mark Drucker, MD, FAAD, Brian S. Kim, MD, FAAD
2:15 PM
Topical Therapy
Lawrence F. Eichenfield, MD, FAAD
2:40 PM
Systemics for Pediatric Patients
Amy S. Paller, MD, FAAD
3:10 PM
Systemic Therapy for Adults -- Available and Emerging
DIRECTOR
Amy S. Paller, MD, FAAD
Northwestern University
SPEAKERS
Lisa A. Beck, MD, FAAD
Dept of Dermatology, University of Rochester Medicine, Rochester, NY
Aaron Mark Drucker, MD, FAAD
University of Toronto
Lawrence F. Eichenfield, MD, FAAD
University of California San Diego and Rady Children's Hospital
Brian S. Kim, MD, FAAD
DISCLOSURES
Lisa A. Beck, MD, FAAD
AbbVie – Consultant (1099 relationship)(Fees); AMGEN – Consultant (1099 relationship)(Honoraria); Apogee BioPharm – Consultant (1099 relationship)(Honoraria); Arcus Biosciences – Consultant (1099 relationship)(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); Arena Pharmaceuticals – Consultant (1099 relationship)(No Compensation Received); AstraZeneca – Consultant (1099 relationship)(Fees); Astria Therapeutics – Consultant (1099 relationship)(Honoraria); Bambusa Therapeutics Inc – Consultant (1099 relationship)(Honoraria); Belharra Therapeutics – Consultant (1099 relationship)(Honoraria); Celldex – Consultant (1099 relationship)(Honoraria); Dermavent – Consultant (1099 relationship)(Honoraria); Eli Lilly and Company – Consultant (1099 relationship)(Fees), Consultant (1099 relationship)(Honoraria); Escient Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); Evommune, Inc. – Consultant (1099 relationship)(Honoraria); Galderma Research & Development, LLC – Consultant (1099 relationship)(Honoraria); Gilead Sciences, Inc – Consultant (1099 relationship)(Honoraria); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Honoraria); Invea Therapeutics – Consultant (1099 relationship)(Honoraria); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Consultant (1099 relationship)(Fees); Medtronics – Stockholder(Stock); Merck & Co., Inc – Consultant (1099 relationship)(Honoraria); Nektar Therapeutics – Consultant (1099 relationship)(Honoraria); Novartis – Consultant (1099 relationship)(Fees); NUMAB Therapeutics AG – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Fees); Regeneron – Consultant (1099 relationship)(Fees); Regeneron Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); ResVita Bio, Inc – Consultant (1099 relationship)(Honoraria); Ribon Therapeutics – Consultant(Honoraria); Sanofi – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Sitryx Therapeutics – Consultant (1099 relationship)(Honoraria); Stealth Biotherapeutics – Consultant (1099 relationship)(Honoraria); TRex Bio – Consultant (1099 relationship)(Honoraria); Triveni Bio – Consultant (1099 relationship)(Honoraria); Tupos Therapeutics – Consultant (1099 relationship)(Honoraria); UCB Pharma – Consultant (1099 relationship)(Honoraria); Union Therapeutics – Consultant (1099 relationship)(Honoraria); Xencor – Consultant (1099 relationship)(Honoraria); Zai Laboratories – Consultant (1099 relationship)(Honoraria);
Aaron Mark Drucker, MD, FAAD
No financial relationships exist with ineligible companies.
Lawrence F. Eichenfield, MD, FAAD
Abbvie – Investigator(Grants/Research Funding); Abeona Therapeutics – Consultant (1099 relationship)(Honoraria); Acrotech Biopharma Inc – Consultant (1099 relationship)(Honoraria); Almirall – Consultant(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Arcutis, Inc. – Consultant (1099 relationship)(Honoraria); Attovia Therapeutics – Consultant (1099 relationship)(Fees); Bristol-Myers Squibb – Consultant(Honoraria); Castle Biosciences – Consultant (1099 relationship)(Honoraria); Castle Biosciences, Inc – Investigator(Grants/Research Funding); Chiesi Farmaceutici – Consultant (1099 relationship)(Honoraria); Dermata Therapeutics – Consultant (1099 relationship)(Stock); Dermavant Sciences, Inc. – Consultant(Honoraria); Eli Lilly – Consultant(Honoraria), Investigator(Grants/Research Funding); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Forte Biosciences – Consultant (1099 relationship)(Honoraria); Galderma Laboratories, L.P. – Consultant(Honoraria), Investigator(Fees); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); Krystal Biotech, Inc – Consultant(Honoraria); Kymera Therapeutics – Consultant (1099 relationship)(Honoraria); LEO Pharma, US – Consultant(Honoraria), Investigator(Fees); Lilly ICOS LLC – Consultant(Honoraria); Novartis – Consultant (1099 relationship)(Honoraria); Organon – Consultant (1099 relationship)(Honoraria); Ortho Dermatologics – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi/Regeneron – Consultant(Honoraria), Investigator(Fees); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); Target RWE – Investigator(Grants/Research Funding); TopMD – Consultant(Stock Options); TRex Bio – Consultant (1099 relationship)(Honoraria); TrialSpark, Inc. – Consultant(Honoraria); UCB – Consultant(Honoraria); Verrica Pharmaceuticals Inc – Board of Directors(Fees), Board of Directors(Stock Options); Wiley-Blackwell – Other(Honoraria);
Brian S. Kim, MD, FAAD
AbbVie – Consultant(Fees); Almirall – Advisory Board(Honoraria); Alys Pharmaceuticals – Stockholder Private Company(Stock); AstraZeneca – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Advisory Board(Honoraria); Evommune, Inc. – Consultant (1099 relationship)(Fees); Galderma – Consultant (1099 relationship)(Fees); Guidepoint Global, LLC – Consultant(Fees); Leo Pharma Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Locus Biosciences – Stockholder(Stock); Novartis – Advisory Board(Honoraria); Pfizer Inc. – Consultant(Honoraria); Recens Medical – Consultant(Fees); Regeneron – Consultant (1099 relationship)(Honoraria); Sanofi – Consultant(Fees); Septerna – Consultant (1099 relationship)(Fees);
Amy S. Paller, MD, FAAD
AbbVie – Data Safety Monitoring Board(Honoraria), Investigator(Grants/Research Funding); Abeona Therapeutics – Data Safety Monitoring Board(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); BioCryst Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); BioMendics, LLC – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria); Castle Creek Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Chiesi Farmaceutici – Consultant (1099 relationship)(Honoraria); Daiichi Sankyo – Data Safety Monitoring Board(Honoraria); Dermavant Sciences, Inc. – Investigator(Grants/Research Funding); Eli Lilly – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Galderma – Data Safety Monitoring Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Johnson & Johnson Innovative Medicine – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Krystal Biotech, Inc – Consultant(Honoraria); L'Oréal France – Consultant (1099 relationship)(Honoraria); Leo Pharma Inc – Consultant(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Honoraria); Pelthos Therapeutics – Consultant (1099 relationship)(Honoraria); Quoin Pharmaceuticals Ltd – Consultant (1099 relationship)(Honoraria); Regeneron – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi Genzyme – Consultant(Honoraria); UCB – Investigator(Grants/Research Funding);